These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2413442)

  • 1. Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes.
    Falo LD; Sullivan K; Benacerraf B; Mescher MF; Rock KL
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6647-51. PubMed ID: 2413442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential ability of fixed antigen-presenting cells to stimulate nominal antigen-reactive and alloreactive T4 lymphocytes.
    Moreno J; Lipsky PE
    J Immunol; 1986 May; 136(10):3579-87. PubMed ID: 3084635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase treatment of accessory cells that have been exposed to antigen selectively inhibits antigen-specific Ia-restricted, but not allospecific, stimulation of T lymphocytes.
    Falo LD; Benacerraf B; Rock KL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6994-7. PubMed ID: 3529095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and biochemical parameters of peptide antigen presentation.
    Thomas DW; Solvay MJ; Hadley G; Betancourt S; Jun S; Nairn R
    Cell Immunol; 1988 May; 113(2):387-403. PubMed ID: 2834074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced T cell responses to antigenic peptides targeted to B cell surface Ig, Ia, or class I molecules.
    Casten LA; Kaumaya P; Pierce SK
    J Exp Med; 1988 Jul; 168(1):171-80. PubMed ID: 2840479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides.
    Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK
    Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of a synthetic multichain polypeptide to class II major histocompatibility complex molecules on antigen-presenting cells and stimulation of a specific T-cell line require processing of the polypeptide.
    Zisman E; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9738-42. PubMed ID: 1946395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation.
    Rock KL; Benacerraf B
    J Exp Med; 1983 May; 157(5):1618-34. PubMed ID: 6189942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ins and outs of MHC class II-mediated antigen processing and presentation.
    Roche PA; Furuta K
    Nat Rev Immunol; 2015 Apr; 15(4):203-16. PubMed ID: 25720354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of antigen-induced proliferation of T cells from radiation-induced bone marrow chimeras by a monoclonal antibody directed against an Ia determinant on the antigen-presenting cell.
    Longo DL; Schwartz RH
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):514-8. PubMed ID: 6165995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antigen association with accessory cells: specific removal of processed antigens from the cell surface by phospholipases.
    Falo LD; Haber SI; Herrmann S; Benacerraf B; Rock KL
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):522-6. PubMed ID: 3467371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of antigen presentation by acidic pH.
    Jensen PE
    J Exp Med; 1990 May; 171(5):1779-84. PubMed ID: 2332737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
    J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of the requirement for antigen processing of pigeon cytochrome c prior to T cell activation.
    Kovac Z; Schwartz RH
    J Immunol; 1985 May; 134(5):3233-40. PubMed ID: 2580020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two roles for Ia in antigen-specific T lymphocyte activation.
    Kim KH; Shivdasani RA; Thomas DW
    J Immunol; 1986 Dec; 137(11):3393-400. PubMed ID: 3491135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of a functional antigen-Ia complex.
    Srinivasan M; Pierce SK
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):919-22. PubMed ID: 2153978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.